Nucleophilic aromatic substitution and Methylation reaction of 2,4-Dichloropyrimidine

2,4-Dichloropyrimidine is a highly versatile and reactive heterocyclic compound that serves as a critical building block in the synthesis of a wide array of biologically active molecules. Its two reactive chlorine atoms, positioned at the 2 and 4 positions of the pyrimidine ring, exhibit differential reactivity, allowing for sequential and regioselective nucleophilic substitutions. This property makes it an ideal scaffold for the construction of diverse molecular architectures, including potent antiviral agents. This document provides detailed application notes and protocols for the synthesis of antiviral compounds utilizing 2,4-dichloropyrimidine as a key starting material, with a focus on diarylpyrimidine non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV-1.

Synthesis of 4-Aryl-5-pyrimidinylimidazoles

Starting from 2,4-dichloropyrimidine, a concise synthetic route to medicinally important 4-aryl-5-pyrimidinylimidazoles is described. Sequential substitution of the 4- and 2-chloro groups using a regioselective Sonogashira coupling, followed by nucleophilic substitution, led to pyrimidinylalkyne derivatives, which were then oxidized to their corresponding 1,2-diketones. In the final and key step, these 1,2-diketones undergo a cyclocondensation reaction with ammonium acetate and a suitable aromatic aldehyde, effectively constructing the imidazole ring and delivering the desired 4-aryl-5-pyrimidinylimidazole products with consistently good overall yields. Synthetic procedure:

Figure 1: Synthesis of 4-Aryl-5-pyrimidinylimidazoles Starting from 2,4-Dichloropyrimidine

To the solution of Pd(PPh₃)₂Cl₂ (0.9 g, 0.005 equiv) and PPh₃ (0.7 g, 0.01 equiv) in a mixed solvent of THF (200 mL) and Et₃N (300 mL), 2,4-dichloropyrimidine (40 g, 0.27 mol, 1 equiv) were added under N₂. After bubbling N₂ into the solution for 15 min, CuI (0.5 g, 0.01 equiv) and trimethylsilylacetylene (29 g, 0.29 mol, 1.1 equiv) were added sequentially. The reaction mixture was heated at reflux temperature for 4.5 h and cooled to rt. The white precipitate (Et₃NHCl) was filtered off and washed with EtOAc. The filtrate solution was concentrated and the residue was diluted with hexanes and loaded directly onto a short pad of silica gel. The product was eluted with 10% EtOAc/hexanes to provide a light orange solid (49.3 g, 0.23 mol, 87%). [1]

Nucleophilic aromatic substitution reaction

Figure 2: Nucleophilic aromatic substitution reaction of 2,4-Dichloropyrimidine

2,4-Dichloropyrimidine (250 mg, 1.68 mmol) and dimethylamine (302 μL, 1.68 mmol, 33% solution in EtOH) were dissolved in DMF (3 mL), followed by the addition of N,N-diisopropylethylamine (6.14 mmol). The resulting reaction mixture was stirred at room temperature overnight, then concentrated to dryness under reduced pressure. The crude residue was purified by flash column chromatography using a gradient of 0–100% EtOAc in heptane to afford the desired product, 2-chloro-N,N-dimethylpyrimidin-4-amine. [1]

Methylation reaction

Figure 3: Methylation reaction of 2,4-Dichloropyrimidine

A 10 mL reaction tube equipped with a magnetic stirring bar was charged with an 2,4-Dichloropyrimidine (0.1 mmol, 1.0 equiv), methanol (25.0 mmol, 250.0 equiv), N-fluorobenzenesulfonimide (0.3 mmol, 3.0 equiv), TFA (0.2 mmol, 2.0 equiv), and 2.0 mL of DCE. The tube was then sealed, and the resulting mixture was strictly de-aerated with nitrogen for 30 minutes. Subsequently, the solution was irradiated with blue LEDs (λ = 405 nm) at room temperature for 20 hours. After the reaction, the mixture was diluted with saturated aqueous NaHCO₃ solution and extracted with ethyl acetate (3 × 5 mL). The combined organic extracts were washed with brine (15 mL), dried over anhydrous Na₂SO₄, and concentrated under reduced pressure. The crude residue was purified by column chromatography on silica gel, eluting with a gradient of petroleum ether/ethyl acetate, to afford 2,4-dichloro-6-methylpyrimidine. [2]

Pharmaceutical applications

A prominent application of 2,4-dichloropyrimidine in antiviral drug discovery is in the synthesis of diarylpyrimidine (DAPY) derivatives. These compounds are potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) that bind to a hydrophobic pocket in the HIV-1 reverse transcriptase (RT), inducing a conformational change that inhibits its enzymatic activity. The following protocol outlines a general synthesis of a diarylpyrimidine NNRTI, starting from 2,4-dichloropyrimidine.

Reference

[1] Mansouri, Mahta ; et al, Exploration and Characterization of the Antimalarial Activity of Pyrimidine-2,4-Diamines for which Resistance is Mediated by the ABCI3 Transporter, ChemMedChem 2026, 21, e202500739.

[2] Huang, Cheng ; et al, Minisci-Type C-H Methylation and Silylation of Heteroarenes with Visible Light and N-Fluorobenzenesulfonimide, Organic Letters 2026, 28, 740-745.

You may like